1-4 of 4
Makia K Manselle
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

LAMP5 Is an AML-Restricted Immunotherapeutic Target Enriched in High-Risk Acute Myeloid Leukemia

Nika Panahi, Tiffany Hylkema, Grace Hawkins, Makia K Manselle, Jack H Peplinski, Logan K Wallace, Rhonda E Ries, Soheil Meshinchi, Danielle C Kirkey
Journal: Blood
Blood (2023) 142 (Supplement 1): 1585.
https://doi.org/10.1182/blood-2023-188352
Published: 2023
Journal Articles

CLEC2A Is a Novel AML-Restricted Immunotherapeutic Target Enriched in KMT2A-Rearranged Acute Myeloid Leukemia

Danielle C Kirkey, Leila Robinson, Derek Janssens, Margaret G Hines, Tiffany Hylkema, Makia K Manselle, Rhonda E Ries, Jack H Peplinski, Logan K Wallace, Dominik Otto, Katherine Tarlock, Steven Henikoff, Wei Li, Soheil Meshinchi
Journal: Blood
Blood (2023) 142 (Supplement 1): 290.
https://doi.org/10.1182/blood-2023-188439
Published: 2023
Journal Articles

Disease Monitoring in Acute Myeloid Leukemia with CLEC2A qRT-PCR

Makia K Manselle, Danielle Kirkey, Rhonda E Ries, Tiffany Hylkema, Nika Panahi, Leila Robinson, Logan K Wallace, Jack H Peplinski, Soheil Meshinchi
Journal: Blood
Blood (2023) 142 (Supplement 1): 6021.
https://doi.org/10.1182/blood-2023-190133
Published: 2023
Journal Articles

Functional Consequence and Therapeutic Targeting of Cryptic ALK Fusions (ALK fus ) in Monosomy7 AML

Makia K. Manselle, Tiffany A. Hylkema, Amanda R. Leonti, Rhonda E. Ries, Quy Le, Scott N Furlan, Soheil Meshinchi
Journal: Blood
Blood (2021) 138 (Supplement 1): 2357.
https://doi.org/10.1182/blood-2021-148179
Published: 2021